Literature DB >> 2824621

Ganciclovir treatment of cytomegalovirus infections in iatrogenically immunocompromised patients.

S Keay1, J Bissett, T C Merigan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2824621     DOI： 10.1093/infdis/156.6.1016

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

Review 1.  Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections.

Authors:  D Faulds; R C Heel
Journal:  Drugs       Date:  1990-04       Impact factor: 9.546

2.  Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice.

Authors:  R H Rubin; P Lynch; M S Pasternack; D Schoenfeld; D N Medearis
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

3.  Effect of 2'-nor-cyclic GMP against guinea pig cytomegalovirus infection.

Authors:  Z H Yang; H L Lucia; R L Tolman; R J Colonno; G D Hsiung
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

4.  Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients.

Authors:  M L Jordan; R L Hrebinko; J S Dummer; D P Hickey; R Shapiro; C A Vivas; R L Simmons; T E Starzl; T R Hakala
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

5.  Application of PCR to multiple specimen types for diagnosis of cytomegalovirus infection: comparison with cell culture and shell vial assay.

Authors:  M J Miller; S Bovey; K Pado; D A Bruckner; E A Wagar
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

6.  (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication.

Authors:  R Snoeck; T Sakuma; E De Clercq; I Rosenberg; A Holy
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

Review 7.  Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

Review 8.  Antiviral agents.

Authors:  E D Reines; P A Gross
Journal:  Med Clin North Am       Date:  1988-05       Impact factor: 5.456
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.